May 29, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Biologics coordinators exert much control over the medications used in rheumatology clinics, with 80% reporting “significant” influence over biosimilar brand selection, according to findings from a recent survey by Spherix Global Insights.“The fact that biologic coordinators report having significant influence over biosimilar brand selection highlights how central these roles
May 29, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Don't Blame DMARDs for Adverse Drug Effects in Rheumatology Patients

Chronic Spontaneous Urticaria Is More Than IgE: New Pathways Drive Targeted Care

EmpiRx Health Leads Discussion on the Evolution of PBMs from Transactional Intermediaries to Value-Based Care Partners at 2026 Nourishing Change Conference

CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo

ORLANDO — Initiation of biologic treatment for asthma is low despite availability, and adherence is low as well despite its…

Prescriptions for an adalimumab biosimilar among new users rose from 0% to 24% after CVS Caremark added it to its formulary, but…

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the…

A primer for U.S. physicians on the role of biosimilars in medical treatment.

Two months after UCB revealed the success of Bimzelx in a head-to-head trial aga | Two months after UCB revealed the success of…

This month’s Healio Exclusive addresses not merely a gap in care for children with rheumatic disease, but what can only be…